WT1 and familial pancreatic carcinoma: Moreover, the chemoimmunotherapy regimen consisted of nab-paclitaxel plus gemcitabine combined with WT1-DC vaccination regulated TME and facilitated conversion surgery for advanced pancreatic cancer patients (54).